REVIEW Tranilast is an antiallergic drug for bronchial asthma. Tranilast exerts its anti-inflammatory and anti-angiogenesis effects through inhibition of expression of MCP-1, TGF-β, and antigen-induced IL-2 lymphocyte responsiveness.
Sato, Tadashi Preparation of N-(3,4-dimethoxycinnamoyl)anthranilic acid as allergy inhibitor Jpn. Kokai Tokkyo Koho (1991), JP 03024046 A 19910201.
Mizukoshi, Seishi Preparation of tranilast Jpn. Kokai Tokkyo Koho (1992), JP 04149165 A 19920522.
Konneh, Matthew Tranilast Kissei Pharmaceutical IDrugs (1998), 1(1), 141-146.
Spitzer MS, Sat M, Schramm C, Schnichels S, Schultheiss M, Yoeruek E, Dzhelebov D, Szurman P (2012). Biocompatibility and antifibrotic effect of UV-cross-linked hyaluronate as a release-system for tranilast after trabeculectomy in a rabbit model--a pilot study. Curr Eye Res. 37(6):463-70. PMID 22577763.